Faster access than browser!
15 relations: Agonist, AM-2201, APICA (synthetic cannabinoid drug), Cannabinoid, Cannabinoid receptor type 1, Cannabinoid receptor type 2, Controlled Substances Act, Designer drug, Drugs controlled by the UK Misuse of Drugs Act, JWH-018, Misuse of Drugs Act 1971, PB-22, QUCHIC, SDB-005, Structure–activity relationship.
Agonist
An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.
New!!: 5F-PB-22 and Agonist · See more »
AM-2201
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.
New!!: 5F-PB-22 and AM-2201 · See more »
APICA (synthetic cannabinoid drug)
APICA (2NE1, SDB-001, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide) is an indole based drug that acts as a potent agonist for the cannabinoid receptors.
New!!: 5F-PB-22 and APICA (synthetic cannabinoid drug) · See more »
Cannabinoid
A cannabinoid is one of a class of diverse chemical compounds that acts on cannabinoid receptors in cells that alter neurotransmitter release in the brain.
New!!: 5F-PB-22 and Cannabinoid · See more »
Cannabinoid receptor type 1
The cannabinoid type 1 receptor, often abbreviated as CB1, is a G protein-coupled cannabinoid receptor located in the central and peripheral nervous system.
New!!: 5F-PB-22 and Cannabinoid receptor type 1 · See more »
Cannabinoid receptor type 2
The cannabinoid receptor type 2, abbreviated as CB2, is a G protein-coupled receptor from the cannabinoid receptor family that in humans is encoded by the CNR2 gene.
New!!: 5F-PB-22 and Cannabinoid receptor type 2 · See more »
Controlled Substances Act
The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated.
New!!: 5F-PB-22 and Controlled Substances Act · See more »
Designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests.
New!!: 5F-PB-22 and Designer drug · See more »
Drugs controlled by the UK Misuse of Drugs Act
Drugs controlled by the United Kingdom (UK) Misuse of Drugs Act 1971 are listed in this article.
New!!: 5F-PB-22 and Drugs controlled by the UK Misuse of Drugs Act · See more »
JWH-018
JWH-018 (1-pentyl-3-(1-naphthoyl)indole) or AM-678 is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with some selectivity for CB2.
New!!: 5F-PB-22 and JWH-018 · See more »
Misuse of Drugs Act 1971
The Misuse of Drugs Act 1971 is an Act of the Parliament of the United Kingdom.
New!!: 5F-PB-22 and Misuse of Drugs Act 1971 · See more »
PB-22
PB-22 (QUPIC or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and detected being sold in synthetic cannabis products in Japan in 2013.
New!!: 5F-PB-22 and PB-22 · See more »
QUCHIC
QUCHIC (BB-22 or 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and was first detected being sold in synthetic cannabis products in Japan in early 2013, and subsequently also in New Zealand.
New!!: 5F-PB-22 and QUCHIC · See more »
SDB-005
SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.
New!!: 5F-PB-22 and SDB-005 · See more »
Structure–activity relationship
commented out as it doesn't appear to be immediately relevant & it is in the wrong place if it is relevant-->The structure–activity relationship (SAR) is the relationship between the chemical or 3D structure of a molecule and its biological activity.
New!!: 5F-PB-22 and Structure–activity relationship · See more »
Redirects here:
5F-PB22, 5F-QUPIC, C23H21FN2O2.
